American Century Companies’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4M | Buy |
848,638
+129,060
| +18% | +$3.71M | 0.01% | 995 |
|
|
2025
Q1 | $24.1M | Buy |
719,578
+242,280
| +51% | +$8.13M | 0.01% | 960 |
|
|
2024
Q4 | $24.4M | Buy |
477,298
+90,412
| +23% | +$4.62M | 0.01% | 950 |
|
|
2024
Q3 | $19.8M | Buy |
386,886
+375,708
| +3,361% | +$19.2M | 0.01% | 1038 |
|
|
2024
Q2 | $501K | Sell |
11,178
-1,380
| -11% | -$61.8K | ﹤0.01% | 2441 |
|
|
2024
Q1 | $588K | Sell |
12,558
-49,050
| -80% | -$2.3M | ﹤0.01% | 2372 |
|
|
2023
Q4 | $2.19M | Buy |
61,608
+32,400
| +111% | +$1.15M | ﹤0.01% | 1749 |
|
|
2023
Q3 | $869K | Buy |
29,208
+9,925
| +51% | +$295K | ﹤0.01% | 2041 |
|
|
2023
Q2 | $347K | Buy |
+19,283
| New | +$347K | ﹤0.01% | 2350 |
|